ÉîÒ¹¸£Àû¹ú²ú¾«Æ·

Peptide therapeutics continue to expand across modalities and indications, yet their ÉîÒ¹¸£Àû¹ú²ú¾«Æ·, Manufacturing and Controls (CMC) present distinctive challenges: complex synthesis routes, diverse impurity profiles (process-, product-, and degradation-related), and evolving regulatory expectations. This course, delivered by Scientific Update, provides a practical, end‑to‑end framework for developing and executing robust impurity management and control strategies for peptide drug substances and drug products. Through a combination of technical lectures, case studies, and interactive exercises, participants will learn how to design phase‑appropriate CMC strategies that accelerate development, reduce risk, and meet global regulatory requirements.